Lifecore Biomedical, Inc. (LFCR) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and thank you for joining LifeCorps earnings call for the second quarter and six months ended June 30th, 2026. During the call, all participants will be in listen-only mode. Now, I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCorps. Good morning, and thank you for joining us. Today, LifeCore Biomedical will provide its earnings results for the second quarter and six months and to June 30th, 2026 and a corporate update. As the company has recently changed its fiscal year end to align with the calendar year, we will be comparing our results for the second quarter and to June 30th, 2026 with a comparable prior year quarter and in May 25th, 2025. For the six month period, we will be comparing our results from January 1st through June 30th, 2026 with the prior year period from November 24, 2024 through May 25, 2025. Hosting the call today from LifeCorps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin, I'd like to remind everyone that today's conference call will contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, August 5, 2026, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our earnings press release, which was furnished to the Securities and Exchange Commission this morning on Form 8K and is available on our corporate website at lifecore.com, as well as are other filin...